リボミック (TSE) · Health Technology. stock live price and technical analysis view. Follow TSE data on Alerta Chart.
Checking data access...
RIBOMIC, Inc. engages in the research and development of molecular targeted drugs using Ribonucleic Acid (RNA) aptamers for use in therapeutic fields. It utilizes the Ribomic Aptamer Therapeutics (RiboART) system to discover new drugs that are applicable to target proteins. The company was founded by Yoshikazu Nakamura on August 1, 2003 and is headquartered in Tokyo, Japan.
With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.
Start for Free